Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
1.550
-0.150 (-8.83%)
At close: Apr 1, 2025, 4:00 PM
1.747
+0.197 (12.69%)
After-hours: Apr 1, 2025, 4:15 PM EDT

Minerva Neurosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
1.44-30.01-32.11-49.911.94
Upgrade
Depreciation & Amortization
0.010.01-0.10.18
Upgrade
Other Amortization
0.020.030.01--
Upgrade
Asset Writedown & Restructuring Costs
---15.2-
Upgrade
Loss (Gain) From Sale of Investments
-----0.09
Upgrade
Stock-Based Compensation
1.331.974.115.229.7
Upgrade
Other Operating Activities
-22.028.287.414.52-
Upgrade
Change in Accounts Payable
-0.20.84-0.880.86-1.32
Upgrade
Change in Unearned Revenue
-----41.18
Upgrade
Change in Other Net Operating Assets
-0.124.1-3.18-0.6-3.06
Upgrade
Operating Cash Flow
-19.55-14.78-24.65-24.6-33.82
Upgrade
Capital Expenditures
---0.02--
Upgrade
Investment in Securities
----24.53
Upgrade
Investing Cash Flow
---0.02-24.53
Upgrade
Issuance of Common Stock
-20--13.69
Upgrade
Other Financing Activities
--0.4-060-0.46
Upgrade
Financing Cash Flow
-19.6-06013.24
Upgrade
Net Cash Flow
-19.554.82-24.6635.43.94
Upgrade
Free Cash Flow
-19.55-14.78-24.66-24.6-33.82
Upgrade
Free Cash Flow Margin
-----82.14%
Upgrade
Free Cash Flow Per Share
-2.58-2.27-4.62-4.61-6.61
Upgrade
Levered Free Cash Flow
-15.48-12.69-20.36-17.086.83
Upgrade
Unlevered Free Cash Flow
-12.63-7.51-15.73-13.136.83
Upgrade
Change in Net Working Capital
0.32-4.944.06-0.414.21
Upgrade
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q